Iron Deficient Erythropoiesis Might Play Key Role in Development of Anemia in Cancer Patients

Oncotarget - United States
doi 10.18632/oncotarget.5658
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Anemia and Iron Deficiency in Cancer Patients: Role of Iron Replacement Therapy

Pharmaceuticals
Molecular MedicinePharmaceutical Science
2018English

Potential Health Economic Impact of Intravenous Iron Supplementation to Erythropoiesis-Stimulating Agent Treatment in Patients With Cancer- Or Chemotherapy-Induced Anemia

Oncology
MedicineCancer ResearchOncology
2011English

PCN34 Cost Analysis of Anemia Treatment With Erythropoiesis-Stimulating Agents (ESAs) in Cancer Patients Receiving Chemotherapy in Italy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

AMDA Leaders Play Key Role in Dementia Summit

Caring for the Ages
2014English

Saturated Fats Play Some Role in the Development of Ovarian Cancer

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1994English

Therapy of Iron-Deficiency Anemia in Gynecological Patients

Medical Council
2019English

Iron Deficiency Anemia in Chronic Hemodialysis Patients

Journal of Japanese Society for Dialysis Therapy
1981English

Supplemental Iron: A Key to Optimizing the Response of Cancer‐Related Anemia to rHuEPO?

Oncologist
Cancer ResearchMedicineOncology
1998English

The Anemia of Infection. Iii. The Uptake of Radio-Active Iron in Iron-Deficient and in Pyridoxine-Deficient Pigs Before and After Acute Inflammation 1

Journal of Clinical Investigation
Medicine
1947English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy